Fri, 17 May 2019 14:30:12: Celltrion and Samsung duel shaping up as both pledge billions of dollars to biologics   

Fri, 17 May 2019 14:26:55: After Oklahoma payout, Purdue faces 5 new state lawsuits over OxyContin

Fri, 17 May 2019 13:53:15: NICE grants Celgene long-awaited thumbs-up for Revlimid in untreated myeloma

Fri, 17 May 2019 13:51:09: Lawmakers clash as Gilead CEO takes congressional hot seat to defend Truvada

Fri, 17 May 2019 10:17:27: FiercePharmaAsia—Post-Shire Takeda outlook; generics price-fixing suit; Daiichi’s leukemia woe

Thu, 16 May 2019 14:48:12: Novartis could settle for $1B as part of federal kickback lawsuit: report

Thu, 16 May 2019 14:22:17: Thermo Fisher snaps up GSK site in Ireland as part of its expansion campaign

Thu, 16 May 2019 13:47:45: Evolus sparks controversy with Cancun beach bash ahead of Jeuveau launch

Thu, 16 May 2019 13:47:22: ASCO data won't help AZ's Calquence rival Imbruvica in CLL: analyst

Thu, 16 May 2019 11:41:12: Xellia to produce antibiotics for hospital-backed Civica Rx  

Thu, 16 May 2019 05:41:46: AbbVie, Roche snag another CLL nod, this time for Venclexta-Gazyva

Wed, 15 May 2019 15:11:59: Novartis’ slow-rolling Kymriah wins coverage in Japan at $305K: report

Wed, 15 May 2019 14:53:06: Takeda addressing Gammagard Liquid supplies but says it will take time

Wed, 15 May 2019 14:28:10: Gilead schemed with J&J, Bristol-Myers to keep their HIV combo monopoly, lawsuit claims

Wed, 15 May 2019 14:23:57: Biogen's Spinraza gets a boost from NICE as competitors loom

Wed, 15 May 2019 13:50:49: Watch out, Dupixent. Pfizer's new JAK inhibitor could come after your eczema market

Wed, 15 May 2019 13:25:39: Pfizer, Merck KGaA's latest Bavencio nod sets up 3-way kidney cancer battle

Wed, 15 May 2019 13:12:13: B. Braun commits $1B to expand in face of IV fluid shortages

Wed, 15 May 2019 13:03:57: Hey, big spender: Pharma's $6.6B TV ad outlay outranks most other industries, report says

Wed, 15 May 2019 02:21:49: Letter to myself: In Merck campaign, cancer patients look back on their diagnoses with heartfelt advice

Tue, 14 May 2019 17:31:05: Lawmakers weigh Part D out-of-pocket cap instead of rebate proposal: report

Tue, 14 May 2019 14:06:17: Bayer's already in the hot seat with investors. A new $2B Roundup slapdown won't help

Tue, 14 May 2019 13:19:40: Novartis recalls liquid version of anemia drug Promacta over risk of contamination from peanut flour

Tue, 14 May 2019 13:03:33: Boehringer buckles in AbbVie patent fight, saving Humira from biosims until 2023

Mon, 13 May 2019 21:54:59: Regeneron's Eylea pads its armor with diabetic retinopathy approval